Display options
Cite
Tagliabue E, Gandini S, Bellocco R, et al. . Cancer Manag Res. 2018;10:1143-1154doi: 10.2147/CMAR.S155283.
Tagliabue, E., Gandini, S., Bellocco, R., Maisonneuve, P., Newton-Bishop, J., Polsky, D., Lazovich, D., Kanetsky, P. A., Ghiorzo, P., Gruis, N. A., Landi, M. T., Menin, C., Fargnoli, M. C., García-Borrón, J. C., Han, J., Little, J., Sera, F., & Raimondi, S. (2018). . Cancer management and research, 101143-1154. https://doi.org/10.2147/CMAR.S155283
Tagliabue, Elena, et al. "." Cancer management and research vol. 10 (2018): 1143-1154. doi: https://doi.org/10.2147/CMAR.S155283
Tagliabue E, Gandini S, Bellocco R, Maisonneuve P, Newton-Bishop J, Polsky D, Lazovich D, Kanetsky PA, Ghiorzo P, Gruis NA, Landi MT, Menin C, Fargnoli MC, García-Borrón JC, Han J, Little J, Sera F, Raimondi S. . Cancer Manag Res. 2018 May 14;10:1143-1154. doi: 10.2147/CMAR.S155283. eCollection 2018. PMID: 29795986; PMCID: PMC5958947.
Copy Download .nbib Format: NLM
Share it on

Cancer Manag Res. 2018 May 14;10:1143-1154. doi: 10.2147/CMAR.S155283. eCollection 2018.

[No title available]

Cancer management and research

Elena Tagliabue, Sara Gandini, Rino Bellocco, Patrick Maisonneuve, Julia Newton-Bishop, David Polsky, DeAnn Lazovich, Peter A Kanetsky, Paola Ghiorzo, Nelleke A Gruis, Maria Teresa Landi, Chiara Menin, Maria Concetta Fargnoli, Jose Carlos García-Borrón, Jiali Han, Julian Little, Francesco Sera, Sara Raimondi

Affiliations

  1. Clinical Trial Center, Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori.
  2. Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.
  3. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  4. Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
  5. Section of Epidemiology and Biostatistics, Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  6. Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NYU Langone Medical Center, New York, NY.
  7. Division of Epidemiology and Community Health, University of Minnesota, MN.
  8. Department of Cancer Epidemiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  9. Department of Internal Medicine and Medical Specialties, University of Genoa.
  10. IRCCS AOU San Martino-IST, Genoa, Italy.
  11. Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
  12. Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
  13. Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua.
  14. Department of Dermatology, University of L'Aquila, L'Aquila, Italy.
  15. Department of Biochemistry, Molecular Biology, and Immunology, University of Murcia.
  16. IMIB-Arrixaca, Murcia, Spain.
  17. Department of Epidemiology, Richard M Fairbanks School of Public Health, Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN, USA.
  18. School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.
  19. Department of Social and Environmental Health Research, London School of Hygiene and Tropical Medicine, London, UK.

PMID: 29795986 PMCID: PMC5958947 DOI: 10.2147/CMAR.S155283

Abstract

PURPOSE: Melanoma represents an important public health problem, due to its high case-fatality rate. Identification of individuals at high risk would be of major interest to improve early diagnosis and ultimately survival. The aim of this study was to evaluate whether

MATERIALS AND METHODS: Data were collected within an international collaboration - the M-SKIP project. The present pooled analysis included data on 3,830 single, primary, sporadic, cutaneous melanoma cases and 2,619 controls from seven previously published case-control studies. All the studies had information on

RESULTS: The presence of any

CONCLUSION: The authors suggest that measuring the

Keywords: cutaneous melanoma; genetic epidemiology; melanocortin 1 receptor; pigmentation; pooled analysis

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

  1. Genet Epidemiol. 2011 Sep;35(6):549-56 - PubMed
  2. Nature. 2003 Apr 24;422(6934):835-47 - PubMed
  3. Nature. 2012 Nov 15;491(7424):449-53 - PubMed
  4. PLoS Genet. 2007 Jan 12;3(1):e9 - PubMed
  5. Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):3-8 - PubMed
  6. BMC Med Res Methodol. 2012 Aug 03;12:116 - PubMed
  7. Genet Med. 2016 Jun;18(6):535-44 - PubMed
  8. J Invest Dermatol. 2016 Sep;136(9):1914-7 - PubMed
  9. Int J Cancer. 2015 Feb 1;136(3):618-31 - PubMed
  10. Cancers (Basel). 2010 Apr 16;2(2):549-66 - PubMed
  11. Hum Mol Genet. 2011 Dec 15;20(24):5012-23 - PubMed
  12. J Natl Cancer Inst. 2011 Aug 17;103(16):1227-35 - PubMed
  13. J Natl Cancer Inst. 2005 Jul 6;97(13):998-1007 - PubMed
  14. Hum Mutat. 2004 Jul;24(1):103 - PubMed
  15. J Natl Cancer Inst. 2004 May 19;96(10):785-95 - PubMed
  16. Hum Mol Genet. 2004 Feb 15;13(4):447-61 - PubMed
  17. J Natl Cancer Inst. 2010 Nov 3;102(21):1618-27 - PubMed
  18. Hum Mutat. 2008 Aug;29(8):E88-94 - PubMed
  19. PLoS One. 2013;8(2):e55712 - PubMed
  20. JAMA. 2008 Mar 19;299(11):1335-44 - PubMed
  21. J Invest Dermatol. 2015 May;135(5):1377-1384 - PubMed
  22. JAMA Dermatol. 2014 Apr;150(4):434-44 - PubMed
  23. Am J Epidemiol. 2004 May 1;159(9):826-33 - PubMed
  24. Ann N Y Acad Sci. 2003 Jun;994:348-58 - PubMed
  25. BMJ. 2012 Jun 18;344:e3996 - PubMed
  26. Pigment Cell Melanoma Res. 2016 Nov;29(6):679-687 - PubMed
  27. Hum Mol Genet. 1997 Oct;6(11):1891-7 - PubMed
  28. Pigment Cell Melanoma Res. 2017 Mar;30(2):273-275 - PubMed
  29. Pigment Cell Melanoma Res. 2014 Sep;27(5):699-720 - PubMed
  30. Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):761-3 - PubMed
  31. BMC Cancer. 2013 Sep 04;13:406 - PubMed
  32. Pigment Cell Melanoma Res. 2012 May;25(3):384-94 - PubMed
  33. PLoS One. 2014 Jul 08;9(7):e101507 - PubMed
  34. J Invest Dermatol. 2012 May;132(5):1452-61 - PubMed
  35. Pigment Cell Res. 2006 Aug;19(4):303-14 - PubMed
  36. Mol Cancer Res. 2012 Jun;10 (6):778-86 - PubMed
  37. Pigment Cell Melanoma Res. 2011 Aug;24(4):728-30 - PubMed
  38. Am J Epidemiol. 2010 Dec 15;172(12):1339-48 - PubMed
  39. JAMA. 2016 Jul 26;316(4):398-400 - PubMed
  40. Int J Cancer. 2008 Jun 15;122(12):2753-60 - PubMed
  41. J Invest Dermatol. 2008 Oct;128(10):2485-90 - PubMed
  42. Int J Cancer. 2011 Oct 1;129(7):1730-40 - PubMed
  43. Nat Genet. 2009 Aug;41(8):920-5 - PubMed
  44. Nat Commun. 2016 Jul 12;7:12064 - PubMed
  45. Eur J Cancer Prev. 2012 Nov;21(6):588-95 - PubMed
  46. BMJ. 1998 Jan 3;316(7124):34-8; discussion 38-9 - PubMed
  47. Exp Dermatol. 2012 Sep;21(9):718-20 - PubMed
  48. Psychol Methods. 2013 Jun;18(2):137-50 - PubMed
  49. J Invest Dermatol. 2001 Aug;117(2):294-300 - PubMed
  50. Pigment Cell Melanoma Res. 2017 Mar;30(2):255-258 - PubMed
  51. Front Genet. 2016 May 31;7:95 - PubMed
  52. J Natl Cancer Inst. 2005 May 18;97(10):715-23 - PubMed
  53. Cancer. 2010 May 15;116(10):2416-28 - PubMed
  54. Eur J Cancer. 2005 Jan;41(1):45-60 - PubMed
  55. Eur J Cancer. 2005 Jan;41(1):28-44 - PubMed
  56. Pigment Cell Res. 2005 Dec;18(6):393-410 - PubMed
  57. Eur J Cancer. 2005 Sep;41(14):2040-59 - PubMed
  58. Int J Epidemiol. 2011 Jun;40(3):780-5 - PubMed
  59. Photochem Photobiol. 2013 Jan-Feb;89(1):219-26 - PubMed
  60. Hum Mol Genet. 2007 Sep 15;16(18):2249-60 - PubMed
  61. Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):437-44 - PubMed
  62. JAMA. 2016 Jul 26;316(4):429-35 - PubMed
  63. Arch Dermatol Res. 2015 Aug;307(6):495-503 - PubMed
  64. JAMA. 2016 Jul 26;316(4):436-47 - PubMed
  65. Int J Cancer. 2013 Jan 15;132(2):385-400 - PubMed
  66. Science. 2006 Jul 28;313(5786):521-2 - PubMed
  67. J Pharmacol Exp Ther. 2012 Aug;342(2):318-26 - PubMed

Publication Types

Grant support